GPO and IDN contracting pressure
Buying groups negotiate category-by-category and can force lower prices or fewer vendors.
- Scope
- U.S. hospital channel
- Materiality
- high
Mobia Medical, Inc. is a U.S.-based medical device company focused on stroke recovery. Its core product is the Vivistim Paired Vagus Nerve Stimulation System, which is used to support therapy for chronic ischemic stroke survivors with upper-extremity motor impairment.
| % | |
|---|---|
| Vivistim System | 90% Implantable neurostimulation system used in stroke rehabilitation therapy. |
| Accessories and replenishment products | 10% Consumable and replacement items sold alongside the installed base. |
The company sells primarily to primary and comprehensive stroke centers in the United States, where the Vivistim System...
Hospitals that perform most Vivistim implants and buy the system for stroke recovery programs.
Higher-acuity stroke hospitals that adopt the system for eligible chronic stroke patients.
Buying groups that negotiate pricing and contract access for affiliated hospitals and ASCs.
Facilities that support post-implant rehabilitation and help drive therapy utilization.
Private and governmental payors that influence adoption through reimbursement coverage.
Mobia Medical generates substantially all of its revenue in the United States, where it sells the Vivistim System to...
The company is focused on expanding commercial reach, adding stroke centers, and increasing awareness of Vivistim...
The product is sold into a concentrated hospital channel, so more field coverage can increase implants and reorders.
Coverage policies directly affect hospital willingness to adopt and patients' access to therapy.
Clinical validation and regulatory compliance reinforce adoption in a specialized medical device market.
Third-party manufacturing must keep pace with demand and quality requirements.
Mobia Medical faces commercialization risk because adoption depends on hospital contracting, reimbursement, and...
Buying groups negotiate category-by-category and can force lower prices or fewer vendors.
Adoption depends on payer policies for procedures using Vivistim.
Single-source or limited suppliers can delay shipments, raise costs, or cause recalls.
Commercial expansion, clinical work, and public-company costs can require additional funding.
Larger medical device and robotics companies have greater scale, resources, and relationships.
MODD · Surgical & Medical Instruments & Apparatus
MOBX · Semiconductors & Related Devices
ESTA · Orthopedic, Prosthetic & Surgical Appliances & Supplies
FOFA · Surgical & Medical Instruments & Apparatus
MNOV · Pharmaceutical Preparations
MedicNova Inc.
MOB.ST · Health Care
Moberg Pharma AB is a Swedish pharmaceutical company focused on the development and commercialization of medical products, particularly in the area of dermatology.
: 16/06/2026